对抑郁症中微RNA的临床见解:桥梁分子发现和治疗潜力
1Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany.
International journal of molecular sciences
|March 13, 2024
概括
微RNAs,调节基因表达的小RNA分子,越来越多地与抑郁症有关. 本综述探讨了它们在抑郁症中的作用以及它们作为诊断生物标志物和治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 抑郁症对全球健康构成重大负担,推动了对诊断和治疗创新的研究.
- 短RNA分子,特别是微RNA,在细胞基因调节中至关重要,并且与抑郁症的病因有关.
- 微RNAs通过转录后调节基因表达,并且可以在外围检测到,从而提供了对中枢神经系统机制的洞察.
研究的目的:
- 对抑郁症中微RNA失调的现有证据进行审查.
- 总结和评估microRNAs作为抑郁症诊断生物标志物的潜力.
- 评估微RNA作为基于RNA的抑郁症治疗点的可行性.
主要方法:
- 对调查抑郁症中microRNA失调的研究进行文献综述.
- 对微RNA功能在基因调节和细胞外囊泡运输方面的研究进行分析.
- 对微RNA作为诊断标记物和治疗剂的现有证据的评估.
主要成果:
- 在抑郁症的病理表型中,microRNAs被证明是失调的.
- 外围微RNA反映了与抑郁相关的中枢神经系统机制.
- 有证据表明,microRNAs作为诊断生物标志物和治疗点具有前景.
结论:
- 微RNA失调是抑郁症的一个关键特征.
- 微RNA代表了开发新型诊断工具和基于RNA的抑郁症治疗方法的有希望的途径.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
49
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.3K
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242
Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
